HYCC™ Platform

The Manufacturing Foundation That Changes Everything.

Veterinary regenerative medicine has long faced a structural barrier 

— companion animal stem cells could not be cultured at commercial scale 

without sacrificing consistency or biological integrity.

The industry's workaround? Pooling cells from multiple donors.
It introduced variability, complicated quality control, and made regulatory pathways harder to navigate.

HYCC™ (High Yield Combinatorial Culture) eliminates the need for pooling entirely.

Through precise, stage-specific control of combinatorial growth factor signals,
HYCC enables stable, high-passage expansion of species-specific adult stem cells 

from a single donor — reproducibly, and at commercial scale.

The result is not just more cells. It is the right cells, consistently produced, batch after batch.

                       P16+

                                            Stable passage achieved in feline adult stem cells

                       Single Donor

                                            No pooling. Commercial-scale production from one tissue source.

                       GMP

                                            Pilot-scale manufacturing and QC completed

Feline adult stem cells. Doubling time (hours) across passages. HYCC™ vs. Conventional culture.